DCC.L vs MCK
DCC.L: A diversified international sales, marketing, and support services group operating in the energy, healthcare, and technology markets. MCK: A global leader in pharmaceutical distribution and healthcare technology services, connecting biopharma, providers, and patients to improve care outcomes.
Side-by-side fundamentals
| Metric | DCC.L | MCK | Edge |
|---|---|---|---|
| Price as of 2026-08-03 close | £63.65 | $877.23 | |
| Market cap as of 2026-08-06 | n/a | $105.4B | |
| P/E as of 2026-08-06 | n/a | 20.77 | |
| PEG as of 2026-08-06 | n/a | 1.70 | |
| Net margin as of 2026-08-06 | n/a | +1.2% | |
| Gross margin as of 2026-08-06 | n/a | +3.6% | |
| Operating margin as of 2026-08-06 | n/a | +1.5% | |
| ROE as of 2026-08-06 | n/a | +39.4% | |
| ROA as of 2026-08-06 | n/a | +5.7% | |
| Debt / equity as of 2026-08-06 | n/a | 1.29 | |
| Revenue growth (YoY) as of 2026-08-06 | n/a | +12.4% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +13.4% | |
| Dividend yield as of 2026-08-06 | n/a | +0.5% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-06 | n/a | 0.30 | |
| 1-year return as of 2026-08-03 close | +36.6% | +23.6% | DCC.L higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.